Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 2, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 80
- Market value to sell
- $105.2M
- Sellers
- 11
- Companies
- 1
- Under 10b5-1 plans
- 65
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Oct 28, 20252:08 PM ET | Heerma PeterOfficer | 2.66K | $79.9K | Oct 28, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Oct 28, 20254:57 PM ET | Dube Eric MOfficer | 92.9K | $2.82M | Oct 28, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Oct 29, 20254:26 PM ET | Dube Eric MOfficer | 27.1K | $817.0K | Oct 29, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Oct 31, 20252:51 PM ET | Heerma PeterOfficer | 5.59K | $195.7K | Oct 31, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Oct 31, 20254:05 PM ET | Coughlin TimothyDirector | 18.0K | $629.7K | Oct 31, 202510b5-1 | Wells Fargo Clearing Services | SEC |
| TVTXTravere Therapeutics, Inc. | Nov 4, 20254:14 PM ET | Sandra CalvinOfficer | 67.1K | $2.42M | Nov 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Dec 1, 20254:09 PM ET | Christopher ClineOfficer | 20.0K | $700.2K | Dec 1, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Dec 15, 20254:05 PM ET | Sandra CalvinOfficer | 2.91K | $104.8K | Dec 15, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Dec 29, 20256:28 AM ET | Rote William E.Officer | 60.0K | $2.41M | Dec 24, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Dec 29, 20256:58 AM ET | Heerma PeterOfficer | 4.98K | $199.2K | Dec 24, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Dec 29, 20259:38 AM ET | Sandra CalvinOfficer | 7.40K | $296.1K | Dec 24, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Dec 29, 20259:39 AM ET | Jula InrigOfficer | 15.0K | $630.0K | Dec 24, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Jan 5, 20267:49 PM ET | Jula InrigOfficer | 2.03K | $81.6K | Jan 5, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Jan 6, 20264:07 PM ET | Jula InrigOfficer | 445 | $16.8K | Jan 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Jan 20, 20264:04 PM ET | Elizabeth ReedOfficer | 10.0K | $273.4K | Jan 20, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Jan 23, 20264:14 PM ET | Dube Eric MOfficer · Director | 8.13K | $244.2K | Jan 23, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Jan 27, 20264:05 PM ET | Dube Eric MOfficer | 51.9K | $1.56M | Jan 27, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 3, 202610:05 AM ET | Rote William E.Officer | 12.4K | $409.1K | Feb 3, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 3, 202611:38 AM ET | Dube Eric MOfficer | 100.1K | $3.29M | Feb 3, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 3, 20269:37 PM ET | Jula InrigOfficer | 6.96K | $223.4K | Feb 3, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 3, 20269:45 PM ET | Christopher ClineOfficer | 7.24K | $232.6K | Feb 3, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 3, 20269:58 PM ET | Sandra CalvinOfficer | 4.33K | $139.2K | Feb 3, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 3, 20269:59 PM ET | Elizabeth E. ReedOfficer | 7.17K | $230.5K | Feb 3, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 4, 20266:00 AM ET | Peter HeermaOfficer | 7.31K | $234.8K | Feb 3, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 4, 20264:01 PM ET | Christopher ClineOfficer | 1.75K | $56.2K | Feb 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 4, 20264:06 PM ET | Jula InrigOfficer | 1.78K | $57.3K | Feb 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 4, 20264:07 PM ET | Elizabeth ReedOfficer | 2.99K | $96.4K | Feb 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 17, 20264:30 PM ET | Elizabeth ReedOfficer | 10.0K | $278.3K | Feb 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Feb 20, 20264:49 PM ET | Dube Eric MOfficer | 60.0K | $1.81M | Feb 20, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Mar 16, 20264:20 PM ET | Elizabeth ReedOfficer | 10.0K | $280.9K | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 1, 20264:06 PM ET | Elizabeth ReedOfficer | 10.0K | $300.0K | Apr 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 1, 20264:13 PM ET | Dube Eric MOfficer · Director | 60.0K | $1.86M | Apr 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 6, 20264:06 PM ET | Roy BaynesDirector | 10.0K | $330.0K | Apr 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 13, 20268:11 PM ET | Christopher ClineOfficer | 65 | $1.88K | Apr 13, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:02 PM ET | Sandra CalvinOfficer | 22.0K | $902.6K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:09 PM ET | Roy BaynesDirector | 32.8K | $1.35M | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:19 PM ET | Elizabeth ReedOfficer | 37.5K | $1.54M | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:20 PM ET | Christopher ClineOfficer | 9 | $369.63 | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20264:27 PM ET | Gary A LyonsOfficer | 8.00K | $245.6K | Apr 14, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20268:40 PM ET | Christopher ClineOfficer | 7.24K | $303.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20268:47 PM ET | Peter HeermaOfficer | 7.21K | $302.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20268:53 PM ET | Jula InrigOfficer | 7.21K | $302.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 14, 20269:17 PM ET | Elizabeth E. ReedOfficer | 7.21K | $302.5K | Apr 14, 2026 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:13 PM ET | Jula InrigOfficer | 1.02K | $43.4K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:14 PM ET | Christopher ClineOfficer | 1.01K | $43.2K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:15 PM ET | Elizabeth ReedOfficer | 6.79K | $283.8K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 15, 20264:16 PM ET | Dube Eric MOfficer | 64.0K | $2.63M | Apr 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | Apr 22, 202610:36 AM ET | Rote William E.Officer | 9.10K | $355.7K | Apr 22, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | May 1, 20264:15 PM ET | Roy BaynesDirector | 9.75K | $431.1K | May 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | May 4, 20264:03 PM ET | Jula InrigOfficer | 20.0K | $900.0K | May 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |